| Lot Release Number |
2019-10-11-0263
|
| FDA Registered Product/Generic Name |
Diphtheria, Tetanus and Acellular Pertussis, Inactivated Poliomyelitis and Haemophilus influenzae Type B Conjugate Vaccine, Adsorbed
|
| Brand Name |
Infanrix-IPV+Hib
|
| Dosage Strength |
0.5 mL
|
| Dosage Form |
Suspension for Injection (Deep I.M.), 2PE Free
|
| Registration Number |
BR-659
|
| Batch/Lot Number |
A20CB546 (DTPa-IPV: AC20B393A; HiB: AHIBD367A)
|
| Packaging Lot |
Packaging lot (box): A20CB546D
Pre-filled syringe: A20LB546D, ED 05-2021
Vial: A20FB546D, MD 10-2018, ED 09-2021;
Needles (25G x 1"): 1902032, ED 2024-01-31
|
| Product Expiration Date |
31 May 2021
|
| Issuance Date |
16 October 2019
|